Highlights Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Market Closed - OTC Markets Other stock markets 03:53:45 2024-04-29 pm EDT			5-day change	1st Jan Change
0.4297 ^USD	+7.42%		+16.14%	-77.96%

Mar. 28	Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Mar. 28	Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M	Mar. 28	MT
Agile Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28	CI
North American Morning Briefing : Stocks Struggle After New Records	Mar. 22	DJ
Agile Therapeutics, Inc. Provides Revenue Guidance for the Full Year Ended December 31, 2023	Feb. 15	CI
Agile Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Agile Therapeutics, Inc. Reaffirms Revenue Guidance for the Full Year 2023	Nov. 09	CI
Earnings Flash (AGRX) AGILE THERAPEUTICS Reports Q3 Revenue $6.7M, vs. Street Est of $6.35M	Nov. 09	MT
Agile Therapeutics, Inc. Affirms Revenue Guidance for the Year 2023	23-08-09	CI
Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q2 Revenue $5.5M	23-08-09	MT
Agile Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Agile Therapeutics, Inc. Provides Revenue Guidance for the Year 2023	23-06-30	CI
Agile Therapeutics Announces the Availability of Twirla® through FPA Women’s Health	23-06-15	CI
Agile Therapeutics, Inc. Announces New Agreement with vitaCare Prescription Services to Improve Access to Twirla	23-06-13	CI
Agile Therapeutics, Inc. announced an agreement to acquire vitaCare Prescription Services, Inc. from GoodRx Holdings, Inc..	23-06-12	CI
Agile Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Agile Therapeutics, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2023	23-05-11	CI
Earnings Flash (AGRX) AGILE THERAPEUTICS Reports Q1 Revenue $3.8M	23-05-11	MT
Agile Therapeutics, Inc. Provides Revenue Guidance for the First Quarter 2023	23-04-28	CI
Earnings Flash (AGRX) AGILE THERAPEUTICS Reports Q4 Revenue $4M, vs. Street Est of $3.13M	23-03-22	MT
Agile Therapeutics, Inc. Reaffirms Revenue Guidance for the Year 2023	23-03-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Highlights

Filters